日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Immunisation with purified Coxiella burnetii phase I lipopolysaccharide confers partial protection in mice independently of co-administered adenovirus vectored vaccines

用纯化的伯氏考克斯体I期脂多糖进行免疫接种,可使小鼠获得部分保护,且该保护作用独立于同时接种的腺病毒载体疫苗。

Dold, Christina; Zhu, Henderson; Silva-Reyes, Laura; Blackwell, Luke; Linder, Aline; Bewley, Kevin; Godwin, Kerry; Fotheringham, Susan; Charlton, Sue; Kim, Young Chan; Pollard, Andrew J; Rollier, Christine S

Inclusion of a dual signal sequence enhances the immunogenicity of a novel viral vectored vaccine against the capsular group B meningococcus

双信号序列的加入增强了新型病毒载体疫苗对B群脑膜炎奈瑟菌荚膜的免疫原性

Sheerin, Dylan; Dold, Christina; Silva-Reyes, Laura; Linder, Aline; Pollard, Andrew J; Rollier, Christine S

First-in-Human Randomized Study to Assess the Safety and Immunogenicity of an Investigational Respiratory Syncytial Virus (RSV) Vaccine Based on Chimpanzee-Adenovirus-155 Viral Vector-Expressing RSV Fusion, Nucleocapsid, and Antitermination Viral Proteins in Healthy Adults

首次人体随机研究,旨在评估基于黑猩猩腺病毒-155病毒载体的呼吸道合胞病毒(RSV)研究疫苗在健康成年人中的安全性和免疫原性,该疫苗表达RSV融合蛋白、核衣壳蛋白和抗终止蛋白。

Cicconi, Paola; Jones, Claire; Sarkar, Esha; Silva-Reyes, Laura; Klenerman, Paul; de Lara, Catherine; Hutchings, Claire; Moris, Philippe; Janssens, Michel; Fissette, Laurence A; Picciolato, Marta; Leach, Amanda; Gonzalez-Lopez, Antonio; Dieussaert, Ilse; Snape, Matthew D

Novel genetically-modified chimpanzee adenovirus and MVA-vectored respiratory syncytial virus vaccine safely boosts humoral and cellular immunity in healthy older adults

新型基因改造的黑猩猩腺病毒和MVA载体呼吸道合胞病毒疫苗可安全增强健康老年人的体液免疫和细胞免疫。

Green, Christopher A; Sande, Charles J; Scarselli, Elisa; Capone, Stefania; Vitelli, Alessandra; Nicosia, Alfredo; Silva-Reyes, Laura; Thompson, Amber J; de Lara, Catherine M; Taylor, Kathryn S; Haworth, Kathryn; Hutchings, Claire L; Cargill, Tamsin; Angus, Brian; Klenerman, Paul; Pollard, Andrew J

Optimization of Zika virus envelope protein production for ELISA and correlation of antibody titers with virus neutralization in Mexican patients from an arbovirus endemic region.

优化寨卡病毒包膜蛋白的生产以用于 ELISA,并将抗体滴度与墨西哥虫媒病毒流行区患者的病毒中和作用进行关联

Kim Young Chan, Lopez-Camacho Cesar, Nettleship Joanne E, Rahman Nahid, Hill Michelle L, Silva-Reyes Laura, Ortiz-Martinez Georgina, Figueroa-Aguilar Gloria, Mar María Antonieta, Vivanco-Cid Héctor, Rollier Christine S, Zitzmann Nicole, Viveros-Sandoval Martha Eva, Owens Raymond J, Reyes-Sandoval Arturo